{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:29:06Z","timestamp":1748269746250},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,15]]},"DOI":"10.7759\/cureus.28044","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:54:57Z","timestamp":1660611297000},"source":"Crossref","is-referenced-by-count":1,"title":["Guillain-Barr\u00e9 Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination"],"prefix":"10.7759","author":[{"given":"Usman","family":"Ilyas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaryab","family":"Umar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubal","family":"Bhangal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deesha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Fayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02450-6","article-title":"Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic","volume":"58","author":"Dewanjee S","year":"2021","unstructured":"Dewanjee S, Vallamkondu J, Kalra RS, Puvvada N, Kandimalla R, Reddy PH. Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic. Mol Neurobiol. 2021, 58:4694-715. 10.1007\/s12035-021-02450-6","journal-title":"Mol Neurobiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13266","article-title":"Neurological manifestations of COVID-19: a systematic review and current update","volume":"142","author":"Whittaker A","year":"2020","unstructured":"Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020, 142:14-22. 10.1111\/ane.13266","journal-title":"Acta Neurol Scand"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15987.2","article-title":"COVID-19 and Guillain-Barre syndrome: a systematic review of case reports","volume":"5","author":"Carrillo-Larco RM","year":"2020","unstructured":"Carrillo-Larco RM, Altez-Fernandez C, Ravaglia S, Vizcarra JA. COVID-19 and Guillain-Barre syndrome: a systematic review of case reports. Wellcome Open Res. 2020, 5:107. 10.12688\/wellcomeopenres.15987.2","journal-title":"Wellcome Open Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2324709620961198","article-title":"A case of Guillain-Barr\u00e9 syndrome associated with COVID-19","volume":"8","author":"Rajdev K","year":"2020","unstructured":"Rajdev K, Victor N, Buckholtz ES, Hariharan P, Saeed MA, Hershberger DM, Bista S. A case of Guillain-Barr\u00e9 syndrome associated with COVID-19. J Investig Med High Impact Case Rep. 2020, 8:2324709620961198. 10.1177\/2324709620961198","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3201\/eid2712.211634","article-title":"Guillain-\u200bBarr\u00e9 syndrome associated with COVID-19 vaccination","volume":"27","author":"Shao SC","year":"2021","unstructured":"Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain-\u200bBarr\u00e9 syndrome associated with COVID-19 vaccination. Emerg Infect Dis. 2021, 27:3175-8. 10.3201\/eid2712.211634","journal-title":"Emerg Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117263","article-title":"Guillain Barr\u00e9 syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series","volume":"420","author":"Sriwastava S","year":"2021","unstructured":"Sriwastava S, Kataria S, Tandon M, et al.. Guillain Barr\u00e9 syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. J Neurol Sci. 2021, 420:117263. 10.1016\/j.jns.2020.117263","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1493415","article-title":"Immunotherapy of Guillain-Barr\u00e9 syndrome","volume":"14","author":"Liu S","year":"2018","unstructured":"Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barr\u00e9 syndrome. Hum Vaccin Immunother. 2018, 14:2568-79. 10.1080\/21645515.2018.1493415","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.05.013","article-title":"Extrapulmonary manifestations of COVID-19: radiologic and clinical overview","volume":"66","author":"Behzad S","year":"2020","unstructured":"Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging. 2020, 66:35-41. 10.1016\/j.clinimag.2020.05.013","journal-title":"Clin Imaging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao L","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al.. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77:683-90. 10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2020.1831606","article-title":"Neurological manifestations in COVID-19: a systematic review and meta-analysis","volume":"34","author":"Chua TH","year":"2020","unstructured":"Chua TH, Xu Z, King NK. Neurological manifestations in COVID-19: a systematic review and meta-analysis. Brain Inj. 2020, 34:1549-68. 10.1080\/02699052.2020.1831606","journal-title":"Brain Inj"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977","volume":"110","author":"Schonberger LB","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al.. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol. 1979, 110:105-23. 10.1093\/oxfordjournals.aje.a112795","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.103005278.x","article-title":"Antecedent symptoms in Guillain-Barr\u00e9 syndrome: an important indicator for clinical and serological subgroups","volume":"103","author":"Koga M","year":"2001","unstructured":"Koga M, Yuki N, Hirata K. Antecedent symptoms in Guillain-Barr\u00e9 syndrome: an important indicator for clinical and serological subgroups. Acta Neurol Scand. 2001, 103:278-87. 10.1034\/j.1600-0404.2001.103005278.x","journal-title":"Acta Neurol Scand"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102875","article-title":"Guillain Barr\u00e9 syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review","volume":"20","author":"Freire M","year":"2021","unstructured":"Freire M, Andrade A, Sope\u00f1a B, et al.. Guillain Barr\u00e9 syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review. Autoimmun Rev. 2021, 20:102875. 10.1016\/j.autrev.2021.102875","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109134-guillain-barr-syndrome-a-sequela-of-the-original-covid-19-infection-or-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:06Z","timestamp":1707507486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109134-guillain-barr-syndrome-a-sequela-of-the-original-covid-19-infection-or-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.28044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,15]]}}}